Bayer AG (XTER:BAYN) 3-Year Revenue Growth Rate : 4.80% (As of Dec. 2023)

View and export this data going back to 1953. Start your Free Trial

What is Bayer AG 3-Year Revenue Growth Rate?

Bayer AG's Revenue per Share for the three months ended in Dec. 2023 was €12.07.

During the past 12 months, Bayer AG's average Revenue per Share Growth Rate was -6.10% per year. During the past 3 years, the average Revenue per Share Growth Rate was 4.80% per year. During the past 5 years, the average Revenue per Share Growth Rate was 4.70% per year. During the past 10 years, the average Revenue per Share Growth Rate was -0.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Bayer AG was 11.10% per year. The lowest was -11.20% per year. And the median was 2.50% per year.

Competitive Comparison of Bayer AG's 3-Year Revenue Growth Rate

For the Drug Manufacturers - General subindustry, Bayer AG's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bayer AG's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bayer AG's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Bayer AG's 3-Year Revenue Growth Rate falls into.

Bayer AG 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Bayer AG (XTER:BAYN) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Bayer AG 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Bayer AG's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Bayer AG (XTER:BAYN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bayer AG (XTER:BAYN) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

BAYZF:USA BAYRY:USA BAYN:Romania BAY:Poland BAYN:Mexico BAY:Italy BAYER:Hungary 0P6S:UK BAYNd:UK BAYN:Austria

Address

Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368

Website

https://www.bayer.com

Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm also has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto.

Bayer AG (XTER:BAYN) Headlines

From GuruFocus

Bayer AG Expects Currency to Ding Earnings by $191.5 Million

By Jacob Maslow Jacob Maslow • 05-21-2018

Market Indexes Lower as Market Considers Outlook

By Julie Young Julie Young • 05-23-2016

Oakmark International Fund Buys Bayer AG, Roche Holding AG, Fresenius Medical Care AG. KGaA, Sells BNP Paribas, Baidu Inc, CNH Industrial NV

By GuruFocus Research GuruFocus Editor • 03-01-2021

Analysts Think Bayer Shares Have Huge Upside

By Barry Cohen Barry Cohen • 03-04-2019

Oakmark International Fund Buys Fresenius Medical Care AG. KGaA, Anheuser-Busch InBev SA/NV, Bayer AG, Sells NAVER Corp, Daimler AG, Valeo SA

By GuruFocus Research GuruFocus Editor • 11-30-2020

David Herro Comments on Bayer

By Holly LaFon Holly LaFon • 04-06-2018